United States· US:72245-193_502384f0-4ffd-5d16-e063-6394a90ad304

Nalocet

A anilides product containing oxycodone and acetaminophen, registered in United States by Forte Bio-Pharma LLC.

In shortageATC N02BEOrange BookUS label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedNalocetATCN02BEREGISTER NO.US:72245-193_502384f0…PACKS LISTED2CHECKEDJune 3, 2026

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
oxycodone and acetaminophen
Manufacturer
Forte Bio-Pharma LLC
Country
United States (US)
ATC code
N02BE
ATC class
Anilides
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
June 3, 2026

Packs & prices · 2

  • ndc11
    7224519303
    30 TABLET in 1 BOTTLE, PLASTIC (72245-193-03)
  • ndc11
    7224519310
    100 TABLET in 1 BOTTLE, PLASTIC (72245-193-10)

Regulatory notes

UNII (FDA substance ID)
362O9ITL9D
ACETAMINOPHEN
RxCUI 161
Orange Book
A040608
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Acetaminophen; Oxycodone Hydrochloride Tablet

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/27fa5d7d-06f5-41b6-b52e-36ed5a1b8ba8
GET /v1/drugs/27fa5d7d-06f5-41b6-b52e-36ed5a1b8ba8?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "362O9ITL9D",
    "rxcui": "161",
    "inchikey": "RZVAJINKPMORJF-UHFFFAOYSA-N",
    "display_name": "ACETAMINOPHEN",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "spl_meta": {
    "f5f7dfca-a5c7-4445-8a5e-9ec62f33f5be": {
      "match": "brand_token",
      "title": "NALOCET (OXYCODONE AND ACETAMINOPHEN) TABLET [FORTE BIO-PHARMA LLC]",
      "spl_version": "8",
      "published_date": "2026-04-27"
    }
  },
  "productid": "72245-193_502384f0-4ffd-5d16-e063-6394a90ad304",
  "productndc": "72245-193",
  "dosage_form": "TABLET",
  "orange_book": {
    "appl_no": "040608",
    "products": [
      {
        "rs": true,
        "rld": false,
        "te_code": null,
        "strength": "300MG;2.5MG",
        "product_no": "001",
        "approval_date": "Dec 30, 2005"
      },
      {
        "rs": true,
        "rld": false,
        "te_code": null,
        "strength": "300MG;5MG",
        "product_no": "002",
        "approval_date": "Dec 30, 2005"
      },
      {
        "rs": true,
        "rld": false,
        "te_code": null,
        "strength": "300MG;7.5MG",
        "product_no": "003",
        "approval_date": "Dec 30, 2005"
      },
      {
        "rs": true,
        "rld": false,
        "te_code": null,
        "strength": "300MG;10MG",
        "product_no": "004",
        "approval_date": "Dec 30, 2005"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": "CII",
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE",
  "shortage_reason": "Acetaminophen; Oxycodone Hydrochloride Tablet",
  "shortage_status": "current",
  "proprietary_name": "Nalocet",
  "active_ingred_unit": "mg/1; mg/1",
  "application_number": "ANDA040608",
  "marketing_category": "ANDA",
  "nonproprietary_name": "oxycodone and acetaminophen",
  "start_marketing_date": "20180523",
  "active_numerator_strength": "300; 2.5"
}

See everything about oxycodone and acetaminophen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.